{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:07:38Z","timestamp":1794665258763,"version":"4.9.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1097\/inf.0000000000001497","type":"journal-article","created":{"date-parts":[[2016,12,25]],"date-time":"2016-12-25T16:59:02Z","timestamp":1482685142000},"page":"e130-e135","source":"Crossref","is-referenced-by-count":15,"title":["Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule"],"prefix":"10.1097","volume":"36","author":[{"given":"Johannes","family":"Tr\u00fcck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sena","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Clutterbuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic F.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merryn","family":"Voysey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210202","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.","volume":"381","author":"Palmu","year":"2013","journal-title":"Lancet"},{"key":"R2-16-20210202","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","article-title":"Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine.","volume":"29","author":"Miller","year":"2011","journal-title":"Vaccine"},{"key":"R3-16-20210202","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R4-16-20210202","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-2600(14)70060-8","article-title":"Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study.","volume":"2","author":"Domingues","year":"2014","journal-title":"Lancet Respir Med"},{"key":"R5-16-20210202","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/infdis\/jiu213","article-title":"Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England.","volume":"210","author":"Moore","year":"2014","journal-title":"J Infect Dis"},{"key":"R6-16-20210202","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/INF.0b013e3182323ac2","article-title":"Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable haemophilus influenzae protein d conjugate vaccine in infants.","volume":"31","author":"Knuf","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R7-16-20210202","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/INF.0000000000000459","article-title":"Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccine.","volume":"33","author":"Quinet","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R8-16-20210202","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review.","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"R9-16-20210202","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"R10-16-20210202","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cid\/cis922","article-title":"Effects of the 10-valent pneumococcal nontypeable haemophilus influenzae protein d-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial.","volume":"56","author":"Van Den Bergh","year":"2013","journal-title":"Clin. Infect. Dis"},{"key":"R11-16-20210202","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jpids\/piw010","article-title":"Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D\u2013Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media\u2014A Double-Blind Randomized Clinical Trial in Finland.","volume":"5","author":"Vesikari","year":"2016","journal-title":"J Pediatr Infect Dis Soc"},{"key":"R12-16-20210202","doi-asserted-by":"crossref","first-page":"e1001657","DOI":"10.1371\/journal.pmed.1001657","article-title":"Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial.","volume":"11","author":"Tregnaghi","year":"2014","journal-title":"PLoS Med"},{"key":"R13-16-20210202","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1182\/blood-2009-03-211052","article-title":"Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans.","volume":"114","author":"Blanchard-Rohner","year":"2009","journal-title":"Blood"},{"key":"R14-16-20210202","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2008.02934.x","article-title":"Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.","volume":"127","author":"Kelly","year":"2009","journal-title":"Immunology"},{"key":"R15-16-20210202","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2567.2006.02436.x","article-title":"The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine.","volume":"119","author":"Clutterbuck","year":"2006","journal-title":"Immunology"},{"key":"R16-16-20210202","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.","volume":"180","author":"Blanchard Rohner","year":"2008","journal-title":"J Immunol"},{"key":"R17-16-20210202","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.4161\/hv.28350","article-title":"Polysaccharide-specific B cell responses to vaccination in humans.","volume":"10","author":"Mitchell","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R18-16-20210202","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00912.x","article-title":"Mechanisms that determine plasma cell lifespan and the duration of humoral immunity.","volume":"236","author":"Amanna","year":"2010","journal-title":"Immunol Rev"},{"key":"R19-16-20210202","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/INF.0000000000001180","article-title":"The antibody response following a booster with either a 10- or 13-valent pneumococcal conjugate vaccine in toddlers primed with a 13-valent pneumococcal conjugate vaccine in early infancy.","volume":"35","author":"Tr\u00fcck","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R20-16-20210202","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/jis212","article-title":"Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells.","volume":"205","author":"Clutterbuck","year":"2012","journal-title":"J Infect Dis"},{"key":"R21-16-20210202","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/cid\/civ274","article-title":"Differential B cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.","volume":"61","author":"van Westen","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R22-16-20210202","doi-asserted-by":"crossref","first-page":"e0144739","DOI":"10.1371\/journal.pone.0144739","article-title":"Direct comparison of immunogenicity induced by 10- or 13-valent pneumococcal conjugate vaccine around the 11-month booster in Dutch infants.","volume":"10","author":"Wijmenga-Monsuur","year":"2015","journal-title":"PLoS One"},{"key":"R23-16-20210202","doi-asserted-by":"crossref","first-page":"e101672","DOI":"10.1371\/journal.pone.0101672","article-title":"Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines\u2014exploratory analyses within a randomised controlled trial.","volume":"9","author":"Khatami","year":"2014","journal-title":"PLoS One"},{"key":"R24-16-20210202","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.","volume":"8","author":"Flasche","year":"2011","journal-title":"PLoS Med"},{"key":"R25-16-20210202","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1016\/j.vaccine.2011.04.004","article-title":"Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.","volume":"29","author":"Tocheva","year":"2011","journal-title":"Vaccine"},{"key":"R26-16-20210202","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.vaccine.2009.03.017","article-title":"Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics.","volume":"27","author":"Poolman","year":"2009","journal-title":"Vaccine"},{"key":"R27-16-20210202","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R28-16-20210202","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.imbio.2012.05.008","article-title":"The zwitterionic type I Streptococcus pneumoniae polysaccharide does not induce memory B cell formation in humans.","volume":"218","author":"Tr\u00fcck","year":"2013","journal-title":"Immunobiology"},{"key":"R29-16-20210202","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.vaccine.2013.03.036","article-title":"The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age.","volume":"31","author":"Blanchard-Rohner","year":"2013","journal-title":"Vaccine"},{"key":"R30-16-20210202","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.4049\/jimmunol.1200451","article-title":"B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody.","volume":"189","author":"Perrett","year":"2012","journal-title":"J Immunol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-201705000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:59:41Z","timestamp":1618279181000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201705000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001497","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}